|
|
|||||||||||
REAPPRAISAL |
Institute of Mental Health
Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Correspondence: Professor Allan H. Young, Institute of Mental Health, University of British Columbia, University Boulevard, Vancouver, British Columbia, Canada V6T 1Z3. 3. Email: allan.young{at}ubc.ca
ABSTRACT
Use of lithium for the treatment of bipolar disorder may be declining even as knowledge of the efficacy and side-effects of lithium has increased. Recent meta-analyses confirm the benefits of maintenance lithium treatment and show that it reduces suicide and suicidality. Psychiatrists should continue to utilise this efficacious treatment for bipolar disorder.
This article has been cited by other articles:
![]() |
R. Morriss and B. Benjamin Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease The British Journal of Psychiatry, August 1, 2008; 193(2): 93 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Adetunji, O. Adetunji, and A. Newton Lithium in mood disorders: a one-sided re-appraisal The British Journal of Psychiatry, May 1, 2008; 192(5): 395 - 395. [Full Text] [PDF] |
||||
Read all eLetters
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |